Poor Glycemic Control Is Associated With Lower Interleukin-2 (IL-2) Levels and Low Macrophage Viability in Chronic

Tuhina Banerjee1, Shailendra Rai2, Aradhana Singh1

  • 1Department of Microbiology, Institute of Medical Sciences, Banaras Hindu University, Varanasi, Uttar Pradesh, India.

Insights

Low macrophage viability and reduced interleukin-2 (IL-2) expression in diabetic foot ulcers (DFUs) are linked to poor wound healing. Elevated hemoglobin A1c levels correlate with these factors, potentially worsening chronic DFU infections.

Area of Science:

  • Immunology
  • Diabetology
  • Microbiology

Background:

  • Chronic diabetic foot ulcers (DFUs) are often complicated by persistent infections.
  • Macrophage dysfunction and altered cytokine profiles may contribute to DFU non-healing.
  • Understanding the interplay between immune cells, inflammatory markers, and microbial load is crucial for DFU management.

Purpose of the Study:

  • To investigate the association between macrophage viability, interleukin-2 (IL-2) expression, and wound microflora in chronic diabetic foot ulcers.
  • To determine the relationship between glycemic control (hemoglobin A1c) and these factors in DFU patients.

Main Methods:

  • Compared macrophage viability and serum levels of IL-1β, IL-2, and IL-10 in DFU patients (n=40) versus controls (n=40).
  • Assessed aerobic and anaerobic microflora in DFUs using culture and molecular methods.
  • Employed statistical analyses including chi-squared, Student's t-test, and Multiple Correspondence Analysis (MCA) to identify associations.

Main Results:

  • Polymicrobial infections were present in 55% of DFUs.
  • Low macrophage viability, often with Gram-negative flora, was observed in 25% of DFU cases.
  • DFU patients exhibited significantly lower serum IL-2 levels (P=.004) and elevated hemoglobin A1c (P=.038) compared to controls.
  • MCA revealed a strong association between low macrophage viability, low IL-2 levels, and elevated hemoglobin A1c.

Conclusions:

  • Elevated hemoglobin A1c levels are significantly associated with reduced IL-2 levels and impaired macrophage viability in chronic DFUs.
  • These immune dysfunctions may be key factors contributing to the persistence of infection and delayed healing in diabetic foot ulcers.

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.5K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.0K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.8K
Psychoneuroimmunology: Diabetes and Cancer01:19

Psychoneuroimmunology: Diabetes and Cancer

Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
49
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
319
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
36